Lifespan Research Institute
banner
lifespanri.bsky.social
Lifespan Research Institute
@lifespanri.bsky.social
Read LRI President Keith Comito’s interview with Boyang Wang, founder of Immortal Dragons, a purpose-driven longevity fund investing in biotech and life-extension projects that prioritize impact over profit.

Available on lifespan.io:
www.lifespan.io/news/boyang-...
Boyang Wang on Targeting Underfunded Longevity Projects
In this interview, Boyang Wang of Immortal Dragons discusses the kinds of projects he wants to fund, ways in which the industry can be encouraged to develop, relationships between the East and West in...
www.lifespan.io
June 9, 2025 at 9:11 PM
We’re proud of our incredible researchers who work every day to advance the science of aging and improve lives around the world. Their dedication drives everything we do at LRI.

And now, thanks to @thermofishersci.bsky.social, they’re doing it in style.

Thank you for the amazing hoodies!
April 24, 2025 at 8:44 PM
We’re excited to share that @keithcomito.bsky.social, President of @lifespanri.bsky.social, will be moderating at the upcoming 2nd annual A4LI Summit in D.C.!

This event will help drive legislative initiatives, accelerating #aging and #longevity research.

Learn more: a4li.org/dc-summit-20...
April 21, 2025 at 4:44 PM
New paper from LRI:
April 4, 2025 at 6:48 PM
Thanks to your feedback in 2022, LRI is funding innovative research on repairing the extracellular matrix through the development of targeted nanodevices to restore damaged elastin, a key protein that keeps arteries flexible.

Learn more: sens.org/restoring-ag...
March 20, 2025 at 4:52 PM
Reposted by Lifespan Research Institute
A new preprint from the Sharma Lab at @lifespanri.bsky.social presents key findings on senescence markers.

This could mean more accurate research and the development of potent senolytic therapies.

lifespan.io/news/using-a-surface-biomarker-to-target-senescent-cells/
By: @arkadimazin.bsky.social
Using a Surface Biomarker to Target Senescent Cells
Scientists have identified a senescence-associated surface protein that can be targeted using antibodies and published their work as a pre-print [1]. This discovery might help distinguish between bene...
lifespan.io
March 14, 2025 at 11:55 PM
How are human clinical trials progressing for treating age-related diseases?

Lifespan.io's Rejuvenation Roadmap tracks the most promising research and tech in longevity science, keeping you up to date on where we are, and what’s ahead.

www.lifespan.io/road-maps/th...
The Rejuvenation Roadmap | Lifespan.io
Want to know when science might reverse human aging? We have compiled the most promising therapies and technologies in development and charted their progress.
www.lifespan.io
February 12, 2025 at 9:26 PM
Today, our postbaccs & grad intern joined "Career Speed Dating," connecting with professionals who took non-academic paths after their PhDs.

Huge thanks to our guests for sharing their expertise & helping students explore diverse science careers!
January 29, 2025 at 2:05 AM
Dr. O’Connor of Cyclarity spoke to Lifespan.io about UDP-003, a drug targeting atherosclerosis.

Cyclarity is entering trials & success could save millions. Good luck to Cyclarity, CMAX, Monash University, & Dr. Nicholls!

Interview:
www.lifespan.io/news/cyclari...
By: @jansen-1975.bsky.social
Cyclarity Launches Human Trial to Cure Atherosclerosis
Recently, Cyclarity Therapeutics announced the launch of a Phase 1 human clinical trial for a drug that aims to remove the arterial plaques that lead to heart attacks and strokes. Tackling the leading...
www.lifespan.io
January 23, 2025 at 7:10 PM
Thank you to everyone who joined us at Shack15 to help kick off the J.P. Morgan Healthcare Conference in San Francisco! It was an afternoon of inspiring discussions and meaningful connections in the longevity biotech space.
January 13, 2025 at 11:18 PM
📢 Last chance to make an impact in 2024! Donate before midnight and help drive progress toward longer, healthier lives. Your contribution funds vital research and innovation to address the challenges of aging.

#endofyeargiving #nonprofit #donate #impact #longevity

www.lifespan.io/eoy-fundrais...
EOY Fundraiser 2024 – LRI | Lifespan.io
...
www.lifespan.io
December 31, 2024 at 7:50 PM
At LRI, a core part of our mission is to train and mentor young scientists, fueling the future of longevity research.

Please help us continue to empower students and advance the field of longevity biotech by making your gift today.

Donate Now: ow.ly/J3Rs50Uqeoz
December 12, 2024 at 8:27 PM
As #GivingWeek comes to a close, we want to say thank you for the incredible support.

With just a few weeks left in the year, we’re asking for your help to finish 2024 strong. Every dollar donated brings us closer to longer, healthier lives.

www.lifespan.io/eoy-fundrais...
December 6, 2024 at 10:24 PM